Document:

<![CDATA[Form of Nonqualified Stock Option Grant Notice & Nonqualified Stock Option ]]>

 Exhibit 10.11 
 GLOBUS MEDICAL, INC. 
 2012 EQUITY INCENTIVE PLAN 

NOTICE OF NONQUALIFIED STOCK OPTION GRANT 
  

							
	  
	  		  		  	
				
	  
	  		  		  	
				
	  
	  		  	Grant Number	  	  

 You have been granted a nonqualified stock option (the “Option”) to purchase shares of the Class A Common
Stock of Globus Medical, Inc. (the “Company”) pursuant to the Globus Medical, Inc. 2012 Equity Incentive Plan, as amended from time to time (the “Plan”), as follows: 

 

							
	Grant Date	  	  
	  		  	
				
	Vesting Commencement Date	  	  
	  		  	
				
	Exercise Price per Share	  	  
	  		  	
				
	Total Number of Shares Granted	  	  
	  		  	
				
	Total Exercise Price	  	  
	  		  	

							
				
	Term/Expiration Date:	  	10 Years/	  	  
	  	

							
		
	Vesting Schedule:	  	Subject to the Plan and the Nonqualified Stock Option Agreement, this Option may be exercised, in whole or in part, in accordance with the following schedule:
(A) one-fourth of the shares subject to the Option shall vest on the date that is one year from the Vesting Commencement Date; and (B) 1/48th of the shares subject to the Option shall vest at the end of each full calendar month thereafter;
provided, that you have not experienced a Termination of Service as of each such vesting date.
		
	Termination Period:	  	The Option may be exercised for up to three months after a Termination of Service, except as set out in Paragraphs 8, 9 and 10 of the Nonqualified Stock Option Agreement
(but in no event later than the Expiration Date); provided, that terminations for Misconduct are governed by Section 11.5 of the Plan, which provides for immediate termination of the Option upon such termination for Misconduct.

 By your signature and the signature of the Company’s representative below, you and the Company agree that this
Option is granted under and governed by the terms and conditions of the Plan and the Nonqualified Stock Option Agreement, all of which are attached and made a part of this document. 

							
	OPTIONEE:	 		 	GLOBUS MEDICAL, INC.
				
	  
	 		 	By:	 	  

				
	  
	 		 	Name:	 	  

	Print Name	 		 		 	
		 		 	Title:	 	  

 Execution Date:                  ,
20     

  
 - 2 -

 GLOBUS MEDICAL, INC. 
 2012 EQUITY INCENTIVE PLAN 
 NONQUALIFED STOCK OPTION AGREEMENT 

This NONQUALIFIED STOCK OPTION AGREEMENT (the “Option Agreement”), dated as of the Grant Date set forth on the Notice of
Nonqualified Stock Option Grant to which this Option Agreement is attached (the “Notice of Grant”), is between Globus Medical, Inc., a Delaware corporation (the “Company”), and the optionee named in the Notice of Grant (the
“Optionee”), an employee or consultant of the Company or of a “Subsidiary,” as defined in the Globus Medical, Inc. 2012 Equity Incentive Plan (the “Plan”), or a non-employee director of the Company. 

WHEREAS, the Company desires to give the Optionee the opportunity to purchase shares of common stock of the Company in accordance with
the provisions of the Plan, a copy of which is attached hereto; 
 NOW THEREFORE, in consideration of the mutual covenants
hereinafter set forth and for other good and valuable consideration, the parties hereto, intending to be legally bound hereby, agree as follows: 
 1. Grant of Option. The Company hereby grants to the Optionee the right and option (the “Option”) to purchase all or any part of an aggregate of that number of Shares set forth on the
Notice of Grant. The Option is in all respects limited and conditioned as hereinafter provided, and is subject in all respects to the terms and conditions of the Plan now in effect and as it may be amended from time to time (but only to the extent
that such amendments apply to outstanding options). Such terms and conditions are incorporated herein by reference, made a part hereof, and shall control in the event of any conflict with any other terms of this Option Agreement. Capitalized terms
not defined in this Option Agreement shall have the meaning given to such terms in the Plan, as amended from time to time. The Option granted hereunder is intended to be a nonqualified stock option meeting the requirements of the Plan, and
not an incentive stock option meeting the requirements of section 422 of the Internal Revenue Code of 1986, as amended (the “Code”). 
 2. Exercise Price. The exercise price of each Share covered by this Option shall be the Exercise Price per Share set forth on the Notice of Grant. It is the determination of the Committee that on
the Grant Date the Exercise Price per Share was not less than the greater of (i) 100% of the Fair Market Value of a Share, or (ii) the par value of a Share. 
 3. Term. Unless earlier terminated pursuant to any provision of the Plan or of this Option Agreement, this Option shall expire on the Expiration Date set forth on the Notice of Grant, which date is
not more than 10 from the Grant Date. This Option shall not be exercisable on or after the Expiration Date. 
 4. Exercise of
Option. The Optionee shall have the right to purchase from the Company such number of Shares and on such dates as are set forth on the Notice of Grant; 

 
provided the Optionee has not experienced a Termination of Service as of the applicable vesting date. The Committee may accelerate any exercise date of the Option, in its discretion, if it deems
such acceleration to be desirable. Once the Option becomes exercisable, it will remain exercisable until it is exercised or until it terminates. 
 5. Method of Exercising Option. Subject to the terms and conditions of this Option Agreement and the Plan, the Option may be exercised by written or electronic notice to the Company at its
principal office, which is presently located at Valley Forge Business Center, 2560 General Armistead Avenue, Audubon, PA 19403. The form of such notice is attached hereto as Exhibit A and shall state the election to exercise the Option
and the number of whole Shares with respect to which it is being exercised; shall be signed by the person or persons so exercising the Option; shall, unless the Company otherwise notifies the Optionee, be accompanied by the investment certificate
referred to in Paragraph 6; and shall be accompanied by payment of the full exercise price of such Shares. Only whole Shares will be issued. 
 The exercise price shall be paid to the Company – 
 (a) in cash or by check;
or 
 (b) following the consummation of a public offering pursuant to an effective registration statement under the Securities
Act covering the offer and sale of common stock, in one or more of the following manners: 
 i. in Shares newly
acquired by the Optionee upon the exercise of the Option; 
 ii. through the delivery of Shares previously
acquired by the Optionee; or 
 iii. by delivering a properly executed notice of exercise of the Option to the
Company and a broker, with irrevocable instructions to the broker promptly to deliver to the Company the amount of sale or loan proceeds necessary to pay the exercise price of the Option; or 

(c) any other form of legal consideration acceptable to the Committee; or 

(d) in any combination of (a), (b) or (c) above. 
 In the event the exercise price is paid, in whole or in part, with Shares, the portion of the exercise price so paid shall be equal to the Fair Market Value of the Shares delivered or withheld on the date
of exercise. 
 In addition, the Optionee must, as a condition to exercising this Option, execute (i) a counterpart
signature page (in the form attached hereto as Exhibit B) to the Amended and Restated Stock Sale Agreement dated as of July 23, 2007 by and among the Company and certain of its stockholders, as amended from time to time (the
“Stock Sale Agreement”); and (ii) a counterpart signature page (in the form attached hereto as Exhibit C) to the Voting Agreement dated as of July 23, 2007 by and among the Company and certain of its stockholders,
as amended from time to time (the “Voting Agreement”); provided, that this condition shall lapse upon the expiration or termination of such agreements. 

  
 - 4 -

 Upon receipt of notice of exercise and payment, the Company shall deliver a certificate or
certificates representing the Shares with respect to which the Option is so exercised. The Optionee shall obtain the rights of a shareholder upon receipt of a certificate(s) representing such Shares. Until such time, the Optionee shall not be, nor
have any of the rights or privileges of, a shareholder of the Company in respect of any Shares issuable upon the exercise of any part of the Option. 
 Such certificate(s) shall be registered in the name of the person so exercising the Option (or, if the Option is exercised by the Optionee and if the Optionee so requests in the notice exercising the
Option, shall be registered in the name of the Optionee and the Optionee’s spouse, jointly, with right of survivorship), and shall be delivered as provided above to, or upon the written order of, the person exercising the Option. In the event
the Option is exercised by any person after the death or Disability of the Optionee, the notice shall be accompanied by appropriate proof of the right of such person to exercise the Option. All Shares that are purchased upon exercise of the Option
as provided herein shall be fully paid and non-assessable. 
 6. Shares to be Purchased for Investment. Unless the
Company has theretofore notified the Optionee that a registration statement covering the Shares to be acquired upon the exercise of the Option has become effective under the Securities Act, and the Company has not thereafter notified the Optionee
that such registration statement is no longer effective, it shall be a condition to any exercise of this Option that the Shares acquired upon such exercise be acquired for investment and not with a view to distribution, and the person effecting such
exercise shall submit to the Company a certificate of such investment intent, together with such other evidence supporting the same as the Company may request. The Company shall be entitled to restrict the transferability of the Shares issued upon
any such exercise to the extent necessary to avoid a risk of violation of the Securities Act (or of any rules or regulations promulgated thereunder), or of any state laws or regulations. Such restrictions may, in the discretion of the Company, be
noted or set forth in full on the Share certificates. 
 7. Non-Transferability of Option. Notwithstanding
anything in Section 11.3 of the Plan to the contrary, (i) this Option is not assignable or transferable, in whole or in part, by the Optionee other than by will or by the laws of descent and distribution, and (ii) during the lifetime
of the Optionee, the Option shall be exercisable only by the Optionee or, in the event of his or her Disability, by his or her guardian or legal representative. 
 8. Termination of Service. If the Optionee experiences a Termination of Service with the Company and Subsidiaries for any reason (other than death or Disability) prior to the Expiration Date, this
Option may be exercised, to the extent of the number of Shares with respect to which the Optionee could have exercised it on the date of such Termination of Service, or to any greater extent permitted by the Committee in its discretion, by the
Optionee at any time prior to the earlier of (i) the Expiration Date, (ii) three months after such Termination of Service if such termination was not for Misconduct, and (iii) the date of such Termination of Service if such
termination was for Misconduct. Shares subject to the unvested portion of the Option shall be forfeited upon the Optionee’s Termination of Service, except to the extent the Committee elects to vest such portion. 

  
 - 5 -

 9. Disability. If the Optionee incurs a Disability during his or her employment and,
prior to the Expiration Date, the Optionee experiences a Termination of Service as a consequence of such Disability, this Option may be exercised, to the extent of the number of Shares with respect to which the Optionee could have exercised it on
the date of such Termination of Service, or to any greater extent permitted by the Committee in its discretion, by the Optionee or by the Optionee’s legal representative at any time prior to the earlier of (i) the Expiration Date or
(ii) one year after such Termination of Service. 
 10. Death. If the Optionee dies during his or her service with
the Company or a Subsidiary and prior to the Expiration Date, or if the Optionee experiences a Termination of Service for any reason (as described in Paragraphs 8 and 9) and the Optionee dies following his or her Termination of Service but
prior to the earliest of (i) the Expiration Date, (ii) the expiration of the period determined under Paragraph 8 or 9 (as applicable to the Optionee), or (iii) three months following the Optionee’s Termination of Service,
this Option may be exercised, to the extent of the number of Shares with respect to which the Optionee could have exercised it on the date of his or her death, or to any greater extent permitted by the Committee in its discretion, by the
Optionee’s estate, personal representative, or beneficiary who acquired the right to exercise this Option by bequest or inheritance or by reason of the Optionee’s death, at any time prior to the earlier of (i) the Expiration Date or
(ii) one year after the date of the Optionee’s death. 
 11. Taxation Upon Exercise of Option; Withholding. The
Optionee understands that, because this Option is a nonqualified stock option, he or she will recognize income for federal income tax purposes at the time the Option is exercised in an amount for each Share equal to the excess of the then Fair
Market Value of a Share over the Exercise Price per Share. The obligation of the Company to deliver shares upon the exercise of this Option shall be subject to applicable federal, state and local tax withholding requirements. If the exercise of the
Option is subject to the withholding requirements of applicable federal, state or local tax law, the Optionee, subject to the provisions of the Plan and such additional withholding rules (the “Withholding Rules”) as shall be adopted by the
Committee, may satisfy the withholding tax, in whole or in part, by electing to have the Company withhold (or by returning to the Company) Shares, which Shares shall be valued, for this purpose, at their Fair Market Value on the date the amount
attributable to the exercise of the Option is includible in income by the Optionee under section 83 of the Code. Such election must be made in compliance with and subject to the Withholding Rules, and the Company may not withhold shares in excess of
that number necessary to satisfy the minimum federal, state and local income tax and Social Security withholding requirements. Notwithstanding the foregoing, the Company may limit the number of Shares withheld to the extent necessary to avoid
adverse accounting consequences. 
 12. Lock-Up Agreement. The Optionee agrees, in connection with the first registration
with the United States Securities and Exchange Commission under the Securities Act of the public sale of the Company’s common stock, not to sell, make any short sale of, loan, grant any option for the purchase of, or otherwise dispose of any
securities of the Company (other than those included in the registration) without the prior written consent of the Company 

  
 - 6 -

 
or such underwriters, as the case may be, for such period of time (not to exceed 180 days) from the effective date of such registration as the Company or the underwriters, as the case may be,
shall specify. Each such recipient agrees that the Company may instruct its transfer agent to place stop-transfer notations in its records to enforce the provisions of this Paragraph. The Optionee also agrees to execute a form of agreement
reflecting the foregoing restrictions as requested by the underwriters managing such offering. 
 13. Company’s Right of
First Refusal. At any time during which the Company has the right of first refusal to purchase any Shares proposed to be sold by the Optionee or any transferee pursuant to the Stock Sale Agreement, the provisions of this Paragraph shall be
inapplicable. If, however, the Company’s rights of first refusal under the Stock Sale Agreement have been terminated, are not in effect, or are not otherwise enforceable against the Optionee or any transferee, the provisions of this Paragraph
shall apply. Before any Shares held by the Optionee or any transferee (either being sometimes referred to herein as the “Holder”) may be sold or otherwise transferred (including transfer by gift or operation of law), the Company or its
assignee(s) shall have a right of first refusal to purchase the Shares on the terms and conditions set forth in this Paragraph (the “Right of First Refusal”). 
 (a) Notice of Proposed Transfer. The Holder of the Shares shall deliver to the Company a written notice (the “Notice”) stating: (i) the Holder’s bona fide intention to sell or
otherwise transfer such Shares; (ii) the name of each proposed transferee (“Proposed Transferee”); (iii) the number of Shares to be transferred to each Proposed Transferee; and (iv) the bona fide cash price or other
consideration for which the Holder proposes to transfer the Shares (the “Offered Price”). The Holder shall at that same time offer the Shares at the Offered Price to the Company or its assignee(s). 

(b) Exercise of Right of First Refusal. At any time within 30 days after receipt of the Notice, the Company and/or its assignee(s)
may, by giving written notice to the Holder, elect to purchase all, but not less than all, of the Shares proposed to be transferred to any one or more of the Proposed Transferees, at the purchase price determined in accordance with
subsection (c) below. 
 (c) Purchase Price. The purchase price (“Purchase Price”) for the Shares
purchased by the Company or its assignee(s) under this Paragraph shall be the Offered Price. If the Offered Price includes consideration other than cash, the cash equivalent value of the noncash consideration shall be determined by the Board in good
faith. 
 (d) Payment. Payment of the Purchase Price shall be made, at the option of the Company or its assignee(s), in
cash (by check), by cancellation of all or a portion of any outstanding indebtedness of the Holder to the Company (or, in the case of repurchase by an assignee, to the assignee), or by any combination thereof within 30 days after receipt of the
Notice or in the manner and at the times set forth in the Notice. 
 (e) Holder’s Right to Transfer. If all of the
Shares proposed in the Notice to be transferred to a given Proposed Transferee are not purchased by the Company and/or its assignee(s) as provided in this Paragraph , then the Holder may sell or otherwise transfer such Shares to that Proposed
Transferee at the Offered Price or at a higher price, provided that such 

  
 - 7 -

 
sale or other transfer is consummated within 90 days after the date of the Notice and provided further that any such sale or other transfer is effected in accordance with any applicable
securities laws and the Proposed Transferee agrees in writing that the provisions of this Paragraph shall continue to apply to the Shares in the hands of such Proposed Transferee. If the Shares described in the Notice are not transferred to the
Proposed Transferee within such period, a new Notice shall be given to the Company, and the Company and/or its assignees shall again be offered the Right of First Refusal before any Shares held by the Holder may be sold or otherwise transferred.

 (f) Exception for Certain Family Transfers. Anything to the contrary contained in this Paragraph notwithstanding, the
transfer of any or all of the Shares during the Optionee’s lifetime or on the Optionee’s death by will or intestacy to the Optionee’s immediate family or a trust for the benefit of the Optionee’s immediate family shall be exempt
from the provisions of this Paragraph. “Immediate Family” as used herein shall mean spouse, lineal descendant or antecedent, father, mother, brother or sister. In such case, the transferee or other recipient shall receive and hold
the Shares so transferred subject to the provisions of this Paragraph, and there shall be no further transfer of such Shares except in accordance with the terms of this Paragraph. 

(g) Termination of Right of First Refusal. The Right of First Refusal shall terminate as to any Shares 90 days after the first
sale of Common Stock of the Company to the general public pursuant to a registration statement filed with and declared effective by the Securities and Exchange Commission under the Securities Act. 

14. Amendment. This Option Agreement may be amended at any time and from time to time by the Committee, provided that the rights
or obligations of the Optionee are not affected adversely by such amendment, unless the consent of the Optionee is obtained or such amendment is otherwise permitted under the terms of the Plan. 

15. Forfeiture and Claw-Back. The Option (including any proceeds, gains or other economic benefit actually or constructively
received by the Optionee upon any exercise of the Option or upon the receipt or resale of any Shares underlying the Option) shall be subject to the provisions of any claw-back policy implemented by the Company, including, without limitation, any
claw-back policy adopted to comply with the requirements of the Dodd-Frank Wall Street Reform and Consumer Protection Act and any rules or regulations promulgated thereunder. 
 16. No Right to Continued Service. Nothing in the Plan or this Option Agreement shall confer upon the Optionee any right to continue in the service of the Company or any Subsidiary or shall
interfere with or restrict in any way the rights of the Company and any Subsidiary, which rights are hereby expressly reserved, to discharge or terminate the service of the Optionee at any time for any reason whatsoever. 

17. Entire Agreement. The Plan and this Option Agreement constitute the entire agreement of the parties and supersede in their
entirety all oral, implied or written promises, statements, understandings, undertakings and agreements between the Company and the Optionee with respect to the subject matter hereof. 

  
 - 8 -

 18. Governing Law. This Option Agreement shall be governed by the applicable Code
provisions to the maximum extent possible. Otherwise, the laws of the State of Delaware (without reference to the principles of conflict of laws) shall govern the operation of, and the rights of the Optionee under, the Plan and options granted
thereunder. 

*        *        *      
  *        * 

  
 - 9 -

 EXHIBIT A 

GLOBUS MEDICAL, INC. 2012 EQUITY INCENTIVE PLAN 
 Notice of Exercise of Nonqualified Stock Option 
 I hereby exercise the
nonqualified stock option granted to me pursuant to the Nonqualified Stock Option Agreement dated as of                  , 20    , by Globus Medical,
Inc. (the “Company”), with respect to the following number of shares of the Company’s common stock (“Shares”), par value $         per Share, covered by said option: 

 

					
		
	 Number of Shares to be purchased:
	  			
		
	 Purchase price per Share:
	  	$	            	  
		
	 Total purchase price:
	  	$	            	  

  

					
	  ̈
	  	A.	  	Enclosed is cash or my check (or other form of legal consideration acceptable to the Compensation Committee of the Company’s Board of Directors) in the amount of
$         in full/partial [circle one] payment for such Shares;
			
		  		  	and/or
			
	  ̈
	  	B.	  	Enclosed is/are Share(s) with a total fair market value of $          on the date hereof in full/partial [circle one] payment for
such Shares;
			
		  		  	and/or
			
	  ̈
	  	C.	  	Please withhold              Shares with a total fair market value of
$         on the date hereof in full/partial [circle one] payment for such Shares;
			
		  		  	and/or
			
	  ̈
	  	D.	  	I have provided notice to              [insert name of broker], a broker, who will render full/partial [circle
one] payment for such Shares. [The Optionee should attach to the notice of exercise provided to such broker a copy of this Notice of Exercise of Nonqualified Stock Option and irrevocable instructions to pay to the Company the full/partial (as
elected above) exercise price.]

 Please have the certificate or certificates representing the purchased Shares registered in
the following name or names*:                     ; and sent to
                    . 
 If
the condition in Paragraph 6 (“Shares to be Purchased for Investment”) of the Nonqualified Stock Option Agreement related to the Shares purchased hereby is applicable, the undersigned hereby certifies that the Shares purchased hereby are
being acquired for investment and not with a view to the distribution of such Shares. 
  

					
	DATED:                  , 20    	 		 	  

		 		 	Optionee’s Signature

  

	*	Certificates may be registered in the name of the Optionee alone or in the joint names (with right of survivorship) of the Optionee and his or her spouse.

  
 - 2-

 EXHIBIT B 

JOINDER TO AMENDED AND RESTATED STOCK SALE AGREEMENT 
 In connection with and as a condition to the receipt by the undersigned of shares of Class A Common Stock of Globus Medical, Inc., a Delaware corporation (the “Company”), the undersigned
hereby executes and agrees to be bound by the terms and conditions of, and shall be deemed a party to, that certain Amended and Restated Stock Sale Agreement, dated as of July 23, 2007, by and among the Company and the other stockholders
thereto, as the same may be amended from time to time (the “Stock Sale Agreement”), as a “Key Holder” thereunder, the form of which has previously been delivered to the undersigned, as if the undersigned had been a party to the
Stock Sale Agreement as of the date thereof. 
  

	
	KEY HOLDERS:
	 
	
	  

(Signature)

	
	
	
	  
 (Print
name)

 Date:                  ,
20     

 EXHIBIT C 

JOINDER TO VOTING AGREEMENT 
 In connection with and as a condition to the receipt by the undersigned of shares of Class A Common Stock of Globus Medical, Inc., a Delaware corporation (the “Company”), the undersigned
hereby executes and agrees to be bound by the terms and conditions of, and shall be deemed a party to, that certain Voting Agreement, dated as of July 23, 2007, by and among the Company and the other stockholders thereto, as the same may be
amended from time to time (the “Voting Agreement”), as a “Key Common Holder” thereunder, the form of which has previously been delivered to the undersigned, as if the undersigned had been a party to the Voting Agreement as of the
date thereof. 
  

	
	KEY COMMON HOLDERS:
	 
	
	  
 (Signature)

	
	
	
	  
 (Print name)

 Date:                  ,
20Employment Agreement

 Exhibit 10.12 
 EXECUTIVE EMPLOYMENT AGREEMENT 
 THIS EXECUTIVE
EMPLOYMENT AGREEMENT (the “Agreement”) is made and entered into this 26th day of March, 2012, and effective January 3, 2012 (the “Effective Date”), by and between Globus Medical, Inc., a Delaware corporation with its principal office in Montgomery County,
Pennsylvania (the “Company”), and Richard Baron, a resident of Pennsylvania (“Executive”), hereinafter collectively referred to as “the Parties”. 
 WITNESSETH: 
 WHEREAS, the Company desires to retain the services of Executive as
Senior Vice President and Chief Financial Officer; and 
 WHEREAS, the Company and the Executive desire to enter into this
Agreement to set forth the terms and conditions of the employment relationship between the Company and Executive; and 

WHEREAS, as a part of said employment by the Company, Executive will have access to confidential and proprietary information of the
Company; and 
 WHEREAS, the Company desires to receive from Executive certain restrictive covenants regarding confidentiality
and certain other covenants each of which is an inducement to Company to employ Executive and a condition of employment; 
 NOW,
THEREFORE, in consideration of the mutual promises in this Agreement, and other good and valuable consideration, including but not limited to the employment of Executive by the Company and the compensation received by Executive from the Company from
time to time, and in particular the issuance of an option to purchase 300,000 shares of common stock in the Company the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as
follows: 
 1. EMPLOYMENT. The Company hereby employs Executive, and Executive hereby accepts such employment. Executive
shall serve as the Senior Vice President and Chief Financial Officer of the Company upon the terms and conditions hereinafter set forth. 
 2. TERM. The term (“Term”) of this Agreement shall begin on the Effective Date and shall continue until terminated in accordance with the provisions of Section 6 hereof. 

3. EMPLOYMENT AT WILL. The Parties acknowledge and agree that Executive’s employment with the Company is, and shall remain at
all times, “employment at-will”. Either party shall have the right to terminate the employment relationship at any time, for any reason, with or without cause or prior notice. 

4. DUTIES; EXCLUSIVE SERVICES; CONFLICTS OF INTEREST. Executive shall faithfully discharge his responsibilities and perform all
duties as generally performed by the 

 
Senior Vice President or Chief Financial Officer of a comparable entity, including any duties set forth in the Bylaws of the Company related to the position and those duties prescribed from time
to time by the President or his designee. Executive agrees to devote his best efforts, time, skill and attention to the performance of his duties and responsibilities on behalf of the Company and in furtherance of its best interests. Executive shall
not become involved in any personal investment or business that would likely adversely affect the business of the Company or its affiliates. Executive also agrees that he shall not, without the written consent of the President or his designee, take
personal advantage of any business opportunities that arise during his employment with the Company and which may benefit the Company. All material facts supporting such opportunities shall be promptly reported to the President for consideration by
the Company. Executive agrees to comply with all policies, standards and regulations of the Company now existing or hereafter promulgated. Subject to the terms and conditions of this Agreement (including, without limitation, Executive’s right
to resign for Good Reason pursuant to Section 6(e)), Executive may be reassigned or transferred to another management position, as designated by and in the discretion of the President or his designee which may or may not provide the same level
of responsibility as the initial assignment, and Executive shall perform these duties. Upon commencing work with the Company, Executive agrees to immediately resign from the board of directors of any entity that engages in any business that competes
with or represents a conflict with the business of the Company as determined in the discretion of the Board of Directors of the Company. 
 5. COMPENSATION. During the Term of this Agreement, Executive’s compensation shall be determined and paid as follows. 

 

	 	(a)	BASE SALARY. Executive shall receive as compensation an initial base salary at the rate of $320,000 annually, which annual rate may be increased during
Executive’s employment from time to time in the sole discretion of the Company (the “Base Salary”). The Base Salary shall be paid on the Company’s regularly scheduled paydays, less federal, state and local payroll taxes and other
withholdings legally required or properly requested by Executive, in accordance with the Company’s regular payroll practices and procedures. 

  

	 	(b)	INCENTIVE BONUS. Subject to the Company’s financial ability, it will establish an incentive bonus plan (“Bonus Plan”) that Executive shall be
eligible to participate in. Under the terms of the Bonus Plan, Executive will be able to earn approximately an additional $145,000 annually (“Target Bonus”) by meeting certain Company and individual performance targets, which amount may be
increased from time to time in the sole discretion of the Company. 

  

	 	(c)	 STOCK OPTION GRANT. Within 30 days following the Effective Date, the Company shall grant to Executive an option to purchase 300,000 shares of
common stock of the Company vesting over a period of four years (vesting commences after one year of service), with an exercise price equal to the fair market value at the time of grant, and conditioned

  
 2 

	 	
on approval by the Company’s Board of Directors and execution of the Globus Stock Option Agreement and related documents. Options shall vest 100% upon acquisition of Company by another
entity. 

  

	 	(d)	BENEFITS. Executive shall be eligible to participate in such other benefits as are provided from time to time to other executive-level employees of the Company.
Such benefits will be provided and administered in accordance with the terms of any such benefit plans. All Company benefits are subject to termination or amendment by the Company without advance notice to or consent from Executive.

  

	 	(e)	VACATION. Executive shall be entitled to four (4) weeks of paid vacation per calendar year, to be accrued and used in accordance with the vacation policy of
the Company. 

  

	 	(f)	BUSINESS EXPENSES. The Company will pay all reasonable expenses incurred by Executive directly related to conduct of the business of the Company, including a
monthly car allowance in the amount of $700.00, provided that Executive complies with the policies for reimbursement or advance of business expenses established by the Company. Executive will also receive the usual and customary benefits allotted to
Company executives including, but not limited to, mobile PDA and laptop computer. 

 6. TERMINATION.
Executive’s employment hereunder may be terminated as follows. 
 (a) VOLUNTARY RESIGNATION BY
EXECUTIVE. Executive may terminate his employment by delivery of written notice to the Company. 
 (b)
TERMINATION BY THE COMPANY WITHOUT CAUSE. The Company may terminate Executive’s employment by delivery of written notice to Executive. 
 (c) TERMINATION BY THE COMPANY FOR CAUSE. While Executive is employed by the Company, the Company may terminate Executive’s employment “for cause,” as hereinafter defined,
immediately upon written notice to Executive. “Cause” shall be decided by a majority vote of the Board of Directors of the Company other than Executive and shall mean: 

(i) Any material breach of the terms of this Agreement by Executive which breach, if curable, is not cured within fifteen (15) days
after written notice of such breach has been given to Executive; or 
 (ii) The failure of Executive to comply with the policies
and/or directives of the Company and/or Board of Directors, which failure, if curable, is not cured within fifteen (15) days after written notice of such failure has been given to Executive; or 

  
 3 

 (iv) Any act of gross negligence or willful misconduct with respect to the Company,
including, without limitation fraud, embezzlement, theft or proven dishonesty in the course of his employment; or 
 (v) Any
failure by Executive to fully disclose any material conflict of interest he may have with the Company in a transaction involving the Company which conflict is materially detrimental to the interest of the Company; or 

(vi) Any adverse act or omission that would be required to be disclosed pursuant to securities laws or that would limit the ability of
the Company or any entity affiliated with the Company to sell securities under any federal or state law or that would disqualify the Company or any affiliated entity from any exemption otherwise available to it, all of which are deemed for purposes
of this Agreement to be materially detrimental to the interests and well-being of the Company. 
 (d) OTHER
TERMINATION BY THE COMPANY. While the Company employs Executive, the Company may immediately terminate this Agreement upon the occurrence of any of the following events: 

(i) This Agreement and Executive’s employment hereunder shall immediately terminate without notice in the event of
death of the Executive. Such termination shall not prejudice any benefits payable to Executive or Executive’s beneficiaries that are fully vested or accrued as of the date of death; however, Executive’s estate will not be entitled to any
other compensation under this Agreement. 
 (ii) This Agreement and Executive’s employment hereunder shall
immediately terminate upon written notice to Executive if Executive is unable, due to a disability, to perform the essential functions of his job, with or without a reasonable accommodation, for a period of sixty (60) continuous days. Such
termination shall not prejudice any benefits payable to Executive or Executive’s beneficiaries that are fully vested or accrued as of the termination date; however, the Company shall have no further obligation or liability to Executive under
this Agreement. 
 (iii) This Agreement shall terminate in the event of the liquidation, dissolution or
discontinuance of business by the Company or the filing of any petition by or against the Company under any federal or state bankruptcy or insolvency laws, which petition shall not be dismissed within sixty (60) days after filing. 

  
 4 

 (e) TERMINATION BY EXECUTIVE FOR GOOD REASON. During the Term of this
Agreement, Executive may terminate his employment under this Agreement at any time for “Good Reason.” For purposes of this Agreement, “Good Reason” means: 

(i) Any materially adverse change or material diminution in the office, title, duties, powers, authority or
responsibilities of Executive; or 
 (ii) Failure of the Company to pay Executive any Base Salary or bonus that
has become due and payable; or 
 (iii) A material reduction in Base Salary; or 

(iv) A relocation of Executive’s principal worksite of more than 25 miles unless such relocation reduces
Executive’s commute to such worksite; or 
 (v) Any material breach of the terms of this Agreement by the
Company. 
 However, none of the foregoing events or conditions will constitute Good Reason unless Executive provides the Company with written
objection to the event or condition within 90 days following the occurrence thereof, the Company does not reverse or otherwise cure the event or condition within thirty (30) days of receiving that written objection, and Executive resigns his
employment within thirty (30) days following the expiration of that cure period. 
 (f) TERMINATION
FOLLOWING CHANGE IN CONTROL. If all or substantially all of the assets of the Company are sold, liquidated or distributed (“Change in Control”), the Company may terminate the Executive’s employment without cause or the Executive
may resign his employment with the Company under circumstances establishing Good Reason. 
 (g) RESIGNATION AS
OFFICER AND DIRECTOR. It is understood that if Executive has been, or at any time hereafter is, appointed to the Board of Directors of the Company, upon termination of this Agreement and Executive’s employment hereunder for any reason,
unless otherwise agree between the Company and Executive, Executive shall also be deemed to have resigned as a member, if applicable at such time, of the Company’s Board of Directors, as well as any and all positions Executive may hold as an
officer of the Company. 
 7. PAYMENTS ON TERMINATION. Upon termination of this Agreement and Executive’s employment
hereunder for any reason, all salary and benefits accrued and unreimbursed expenses due as of the date of termination shall be paid to Executive on the Company’s next regular payday. 

(a) Termination Without Severance Benefits. If this Agreement and Executive’s employment hereunder is
terminated (i) by Executive for any reason other than Good Reason, including but not limited to termination pursuant to Subsection 6(d) 

  
 5 

 
above, or (ii) pursuant to Subsection 6(a) (voluntary resignation), or Subsection 6(c) (by the Company for “Cause”), no other payment or severance benefit will be payable to
Executive by the Company. 
 (b) Termination with Severance Benefits. If Executive’s employment is
terminated pursuant to Subsection 6(b) (by the Company without “Cause”), 6(e) (for “Good Reason”) or 6(f) (“Change in Control”), then Executive shall be entitled to receive: (i) a severance equal to the Base Salary
paid in equal installments each month over a period of twelve (12) months; and (ii) reimbursement for monthly premiums paid by Executive for his (and, if applicable, his spouse’s and dependents’) continued coverage pursuant to
the Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”) under the group health, dental and/or vision plans sponsored by the Company (or any of its affiliates) for a period of twelve (12) months. In addition, if
Executive’s employment is terminated pursuant to Subsection 6(b), 6(e) or 6(f) on or before the first anniversary of the Effective Date, then 1/48th of the shares subject to the stock option granted pursuant to Section 5(c) hereof shall
vest at the end of each full calendar month beginning on the Effective Date and ending on the date of Executive’s termination. 
 Notwithstanding the foregoing, no amount shall be payable to Executive under this Section 7 unless at the time of resignation or termination, Executive has been employed by Company for more than
three (3) months from the Effective Date. 
 Further, notwithstanding the foregoing, the severance benefits described in the
preceding paragraph are conditioned on Executive’s execution and delivery to the Company and the expiration of all applicable statutory revocation periods, by the 60th day following the effective date of his cessation of employment, of a
general release of claims against the Company substantially in the form attached hereto as Exhibit A (the “Release”). Subject to the following paragraph, the severance benefits described in the preceding paragraph will be begin to
be paid or provided as soon as administratively practicable after the Release becomes irrevocable, provided that if the 60-day period described above begins in one taxable year and ends in a second taxable year such payments or benefits shall not
commence until the second taxable year. 
 Notwithstanding anything to the contrary in this Agreement, no portion of the benefits
or payments to be made under Section 7(b) hereof will be payable until Executive has a “separation from service” from the Company within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended (the
“Code”). In addition, to the extent compliance with the requirements of Treas. Reg. § 1.409A-3(i)(2) (or any successor provision) is necessary to avoid the application of an additional tax under Section 409A of the Code to
payments due to Executive upon or following his “separation from service”, then notwithstanding any other provision of this Agreement (or any otherwise applicable plan, policy, agreement or arrangement), any such payments that are
otherwise due within six months following Executive’s “separation from service” (taking into account the preceding sentence of this paragraph) will be deferred without interest and paid to Executive in a lump sum immediately following
that six month period. This paragraph should not be construed to prevent the application of Treas. Reg. § 1.409A-1(b)(9)(iii) 

  
 6 

 
(or any successor provision) to amounts payable hereunder. For purposes of the application of Section 409A of the Code, each payment in a series of payments will be deemed a separate
payment. 
 8. WITHHOLDING FROM AND OFFSET OF SEVERANCE BENEFITS. The obligation of the Company to make any payment
pursuant to Section 7 of this Agreement shall be subject to the following: 
 (a) Taxes. The Company
shall withhold all applicable federal, state and local taxes as required by relevant law and regulation then in effect including, without limitation FICA and other taxes. 

(b) Debts and Liabilities of Executive. The Company may withhold from or offset against its payment(s) to Executive
any liabilities or debts of Executive to the Company. 
 9. Section 409A. 

(a) Notwithstanding anything herein to the contrary or otherwise, except to the extent any expense, reimbursement or
in-kind benefit provided to Executive does not constitute a “deferral of compensation” within the meaning of Section 409A of the Code, and its implementing regulations and guidance, (i) the amount of expenses eligible for
reimbursement or in-kind benefits provided to Executive during any calendar year will not affect the amount of expenses eligible for reimbursement or in-kind benefits provided to Executive in any other calendar year, (ii) the reimbursements for
expenses for which Executive is entitled to be reimbursed shall be made on or before the last day of the calendar year following the calendar year in which the applicable expense is incurred and (iii) the right to payment or reimbursement or
in-kind benefits hereunder may not be liquidated or exchanged for any other benefit. 
 (b) Anything to the
contrary herein notwithstanding, all benefits or payments provided by the Company to Executive that would be deemed to constitute “nonqualified deferred compensation” within the meaning of Section 409A of the Code are intended to
comply with Section 409A of the Code. Notwithstanding anything in this Agreement to the contrary, distributions may only be made under this Agreement upon an event and in a manner permitted by Section 409A of the Code or an applicable
exemption. 
 (c) If the application of Section 409A impacts Company’s tax liability, then Executive
agrees to reimburse Company in the amount of the liability incurred. 
 10. CONFIDENTIALITY; RESTRICTIVE COVENANTS; INVENTION
ASSIGNMENT. As a material inducement to the Company to employ Executive and pay Executive compensation as set forth herein, Executive agrees to the covenants and terms set forth in the Parties’ “No Competition and Non-Disclosure
Agreement”, attached hereto as Exhibit B, the terms and conditions of which are incorporated by reference into this Agreement as if fully set forth herein. 

  
 7 

 (a) Acknowledgments. Executive acknowledges and agrees that the
restrictive covenants and obligations set forth in this Section 10 impose a reasonable restraint on Executive in light of the activities and business of the Company. Executive further acknowledges and agrees that the restrictive covenants and
obligations set forth in this Section 10 shall not prevent him from earning a livelihood upon the termination of his employment with the Company and merely prevent unfair competition with the Company for a limited period of time and protect
legitimate interests that the Company has in its good will, investments in training, and trade secret or confidential information. Executive acknowledges and agrees that the Company would not employ Executive, train Executive, or provide Executive
with access to the trade secrets or confidential information of the Company unless Executive were willing to agree to the restrictive covenants and obligations set forth in this Section 10. Executive further acknowledges that the covenants and
obligations set forth herein are of the essence of this Agreement; they shall be construed as independent of any other provision in this Agreement; and the existence of any claim or cause of action of Executive against the Company, whether
predicated on this Agreement or not, shall not constitute a defense to the enforcement by the Company of these covenants. 
 11.
EXECUTIVE REPRESENTATIONS. Executive warrants and represents as follows: 
 (a) Executive represents that
his performance of all of the terms of this Agreement does not and will not breach any arrangement to keep in confidence information acquired by Executive in confidence or in trust prior to Executive’s employment by the Company. Executive
represents that he has not entered into, and agrees not to enter into, any agreement either oral or written in conflict herewith. 
 (b) Executive understands as part of the consideration for this Agreement and for Executive’s employment or continued employment by the Company, that Executive has not brought and will not bring with
Executive to the Company, or use in the performance of Executive’s duties and responsibilities for the Company or otherwise on its behalf, any materials or documents of a former employer or other owner that are generally not available to the
public, unless Executive has obtained written authorization from the former employer or other owner for their possession and use and has provided the Company with a copy thereof. 

(c) Executive understands that during his employment for the Company he is not to breach any obligation of confidentiality
that Executive has to a former employer or any other person or entity and agrees to comply with such understanding. 
 12.
RECORDS. All notes, data, tapes, reference materials, sketches, drawings, memoranda, models and records in any way relating to any of the proprietary information or to the Company’s business shall belong exclusively to the Company, and
Executive agrees to turn 

  
 8 

 
over to the Company all such materials and all copies and reproduction capabilities concerning such materials or compilations of information therefrom in his possession or then under his control
at the request of the Company or, in the absence of such request, upon the termination of Executive’s employment with the Company. 
 13. WAIVER. No waiver of any provision of this Agreement shall be valid unless the same is in writing and signed by the party against whom such waiver is sought to be enforced. Failure or delay of
the Company at any time to insist upon strict compliance with any of the terms, covenants or conditions hereof, or to exercise any of its powers, rights or remedies with respect to any term or provision of this Agreement or any other aspect of
Executive’s conduct or employment, shall not be deemed a waiver of such terms, covenants, conditions, powers, rights or remedies, nor shall any waiver or relinquishment of any right or power granted hereunder at any particular time be deemed a
waiver or relinquishment of such rights or power at any other time or times. 
 14. REMEDY. Executive understands and
agrees that the Company will suffer irreparable harm in the event that Executive breaches any of his obligations under Section 10 hereof and that monetary damages will be inadequate to compensate the Company for such breach. Accordingly,
Executive agrees that, in the event of a breach or threatened breach by Executive of any of such provisions of this Agreement, the Company, in addition to and not in limitation of any other rights, remedies or damages available to the Company at law
or in equity, shall be entitled to injunctive relief in order to prevent or to restrain any such breach by Executive, or by Executive’s partners, agents, representatives, servants, employers, employees and/or any and all persons directly or
indirectly acting for or with him. 
 15. SEVERABILITY. The provisions of this Agreement shall be deemed severable, and
the invalidity or unenforceability of any provision (or part thereof) of this Agreement shall in no way affect the validity or enforceability of any other provision (or remaining part thereof) or the enforceability thereof under different
circumstances. 
 16. GOVERNING LAW; VENUE. This Agreement shall be governed by and construed according to the laws of
the Commonwealth of Pennsylvania, without reference to the choice of law or conflict of law provisions of such laws, provided that federal law shall govern copyright, patent and trademark issues. The Parties further agree that the Court of Common
Pleas of Montgomery County, Pennsylvania or the United States District Court for the Eastern District of Pennsylvania in Philadelphia, Pennsylvania shall adjudicate any disputes related to this Agreement. The parties hereto consent to the personal
jurisdiction of such courts. 
 17. NOTICES. Any notice required to be given hereunder shall be sufficient if in writing
and sent by certified or registered United States mail, return receipt requested, first-class postage prepaid, in the case of Executive, to the last known address as shown on the Company’s records, and in the case of the Company, to its
principal office in the Commonwealth of Pennsylvania. 
 18. BENEFIT. This Agreement shall be binding upon and shall
inure to the benefit of each of the parties hereto, and to their respective heirs, representatives, successors and permitted assigns. Executive may not assign any of his rights or delegate any of his duties under this Agreement. 

  
 9 

 19. ENTIRE AGREEMENT. This Agreement, and the No Competition and Non-Disclosure
Agreement attached hereto as Exhibit B, contain the entire agreement and understandings by and between the Company and Executive with respect to the covenants herein described, and no representations, promises, agreements or understandings,
written or oral, not herein contained shall be of any force or effect. No change or modification hereof shall be valid or binding unless the same is in writing and signed by the Parties hereto. Executive represents and agrees that he fully
understands his right to discuss all aspects of this Agreement with counsel of his choice, that to the extent he desired, he availed himself of this right, that he has carefully read and fully understands the meaning, intent and consequences of all
provisions of this entire Agreement, that he is competent to execute this Agreement, that his decision to execute this Agreement has not been obtained by any duress, and that he freely and voluntarily enters into this Agreement. 

20. CAPTIONS. The captions in this Agreement are for convenience only and in no way define, bind or describe the scope or intent
of this Agreement. 
 21. SURVIVAL. The provisions set forth in Sections 7 through 20 hereof shall survive the
termination of this Agreement and any period of applicability stated therein shall be extended to the extent of any period of time during which the Executive is in violation thereof. 

IN WITNESS WHEREOF, the parties have executed this Executive Employment Agreement effective as of the day and year first above written.

  

			
	GLOBUS MEDICAL, INC.

 
			
		
	By:	 	 /s/ David Demski

			
	Name:	 	David Demski

 
			
	Title:	 	President & COO
	
	EXECUTIVE
	
	 /s/ Richard Baron

	Richard Baron

  
 10 

 EXHIBIT A 
 Form of Release 
 SEPARATION AGREEMENT AND GENERAL RELEASE 

In consideration of a payment of: (1)              representing a
severance payment of      salary which I will receive from Globus Medical, Inc. (“Globus”) by check (less appropriate payroll taxes which will be withheld); and
(2)              representing the cost of extending my medical and health benefits for      months, both payments to be sent within
         (    ) calendar days after Globus receives a signed copy of this Agreement, I,             , intending to be legally
bound by this Separation Agreement and General Release (“Agreement”), hereby agree to release Globus from all claims, demands, actions or liabilities I may have against Globus of whatever kind, known or unknown, including but not limited
to those which arise out of or are related to my employment with Globus or the separation or termination of that employment. I agree that this also releases from liability Globus’ subsidiaries, successors, operating units, assigns, affiliates,
related corporations and entities, and all of their present and future partners, principals, shareholders, employees, officers, directors, agents, attorneys, divisions, and any person or entity which can be held jointly and severably liable with any
of them (hereinafter, “those associated with Globus”). 
 I agree that I have voluntarily executed this release on my
own behalf, and also on behalf of any heirs, agents and representatives that I may have now or in the future. I knowingly and voluntarily waive any and all claims under any and all laws which provide legal restrictions on Globus’ or the rights
of those associated with Globus to terminate my employment or to affect the terms and conditions of my employment, including but not limited to claims under any federal, state, or other governmental statute, regulation or ordinance, including,
without limitation: (1) Title VII of the Civil Rights Act of 1964 and the Civil Rights Act of 1991; (2) the 

  
 11 

 
Americans With Disabilities Act; (3) the Pennsylvania Human Relations Act; (4) the Age Discrimination in Employment Act (“ADEA”); (5) the Older Workers Benefit Protection
Act; (6) The Family and Medical Leave Act (“FMLA”); (7) Sections 1981 through 1988 of Title 42 of the United States Code; (8) the Employee Retirement Income Security Act of 1974 (“ERISA”); (9) the federal Food
Drug and Cosmetic Act; (10) the Occupational Safety and Health Act; (11) all other federal, state or local laws of a similar nature to any of the foregoing enumerated laws and any amendments to the foregoing statutes. 

I also waive any other common law or statutory claims against Globus and those associated with Globus, including but not limited to any
claim for personal injury, wrongful discharge, public policy, negligence, infliction of emotional distress, whistleblower, retaliation, negligent hiring or retention, or any form of tort, whether negligent, reckless or intentional, or any claims
based on theories of contract, including any claims for legal fees or costs, or any other form of action. 
 I understand that I
am not waiving any rights or claims under the ADEA that may arise after the date this waiver is executed, but does waive any claims pertaining to my separation from employment as provided for by this Agreement. I also understand that I am not
waiving any rights or claims which cannot legally be waived by this Agreement, including without limitation, unemployment compensation claims, workers’ compensation claims or the ability to file certain administrative claims. 

I understand that nothing in this Agreement shall interfere with my right to file a charge with, cooperate with, or participate in an
investigation or proceeding conducted by the Equal Employment Opportunity Commission or other federal or state regulatory or law enforcement agency. However, I agree that, with the exception of unemployment and worker’s

  
 12 

 
compensation claims, the consideration provided to me in this Agreement shall be the sole relief provided for the claims that are released by me herein and I understand that I will not be
entitled to recover and agree to waive any monetary benefits or economic recovery or equitable relief recovery against Globus or those associated with Globus in connection with any such claim, charge or proceeding without regard to who has brought
such complaint or charge. 
 Subject to all of the foregoing, this Agreement shall operate as a general release of any and all
claims to the fullest extent of applicable law. 
 I further acknowledge and agree that: 

1. The payment as described above constitutes consideration for this release, in that it is a payment or other accommodation to which I would not have
been entitled under any Globus policy, procedure or plan had I not signed this release. 
 2. As of the date set forth below, payment has been
made in full for all hours worked and that I am not owed or entitled to any additional compensation in the form of salary, wages, overtime, vacation pay, fringe benefits or otherwise, related to any employment with Globus or those associated with
Globus. 
 3. I have been given the opportunity to take a period of at least twenty-one (21) days to consider this release
(“Consideration Period”), I have not been pressured or coerced to waive this Consideration Period, and I have been given the opportunity to discuss it with counsel of my choice. 
 4. I have carefully read this release, have had a reasonable time to review it, and have signed it voluntarily, without coercion and with knowledge of the nature and consequences thereof. 

  
 13 

 5. This release does not waive any claims I may have which arise after the date I sign this release.

 6. I have not relied on any representations or promises of any kind made to me in connection with my voluntary decision to sign this release
except for those set forth in this release. 
 7. I will keep the terms of this release, including the payment and accommodations made
hereunder, in strict confidence, and will not make public or disclose the terms or payment to any person except for my spouse, my attorneys or accountants or governmental authorities as may be required by law. 

8. I shall not make or publish any statement (orally or in writing) or instigate, assist or participate in the making or publication of any statement
which shall tend to disparage or demean Globus, or any of its present or former employees, officers and directors. 
 9. If Globus receives any
requests for references concerning my employment, Globus will only disclose my position and dates of employment. 
 10. I agree not to seek
employment or be employed with Globus or those associated with Globus, and forever waive and relinquish all rights to assert any claim for recall, reemployment, or tenure with Globus or those associated with Globus. I agree that Globus and those
associated with Globus need not accept or consider any application for employment from me, may deny employment to me based upon this provision, and I hereby release Globus and those associated with Globus from any liability for failure to hire or
rehire me in the future. If I should apply for employment or reemployment with Globus or those associated with Globus in the future, this Agreement shall constitute my irrevocable request that such application be withdrawn and not considered and, if
already hired, shall constitute my irrevocable resignation. 

  
 14 

 11. I agree I will never institute or be a party to a claim of any kind against Globus or those associated
with Globus regarding the subject matter of this release. If I violate this release by instituting a claim against Globus or those associated with Globus, I agree I will pay all costs Globus or those associated with Globus incur in defending against
the claim, including reasonable attorneys’ fees. 
 12. I agree to timely pay any taxes due on sums paid pursuant to this Agreement and
hereby indemnify and holds harmless Globus for any taxes and penalties assessed on account of sums paid pursuant to this Agreement. 
 13. I
understand that the sums paid pursuant to this Agreement will not be included in compensation for purposes of calculating the benefits to which I am entitled under any 401(k), pension or other retirement plan. 

14. I agree to execute any documents and to take any other actions necessary to implement the terms of this Agreement. 

15. I understand that this Agreement sets forth the terms of the entire agreement between me and Globus concerning my employment and separation from
employment and extinguish the terms of any other agreement between the parties; provided, however, that the provisions of the No Competition and Non-Disclosure Agreement that I signed as an employee of Globus shall remain in full force and effect. I
am not entitled to any benefit or consideration not set forth in this Agreement nor shall I be entitled to any duplication of the consideration or benefits described in this Agreement. 
 16. I understand that no oral statement of any person whatsoever shall in any manner or degree modify or otherwise affect the terms and provisions of this Agreement. To the extent the terms of this
Agreement and any other agreement conflict, the terms of this Agreement shall govern and supercede such inconsistent terms. 

  
 15 

 17. I understand and agree that if, after 60 days from receipt of this Agreement, I do not sign and return
it to Globus, that the terms and conditions of this offer shall expire at Globus’ discretion and without any further notice to me. 
 I understand this Agreement is not effective or enforceable for seven (7) days after I sign it, and I may revoke it during that time (“Revocation Period”). I have not been pressured or
coerced to waive this Revocation Period. To revoke, I agree to return the full amount of any check I received from Globus under this Release, together with a written notice of revocation addressed to Kelly G. Huller, Esquire, Vice President, Legal,
Globus Medical, Inc., 2560 General Armistead Avenue, Audubon, PA 19403. I understand and agree that this must be done before the conclusion of the seventh day after I sign the release; that if Ms. Huller does not receive a written revocation
and the sum stated above by the end of the seven day period, this release will become fully enforceable at that time; and that revocation of this release does not alter or affect the termination of my employment with Globus. 

In case any part of this release shall be invalid, illegal or otherwise unenforceable, the validity, legality and enforceability of the
remaining provisions shall not in any way be affected or impaired thereby. This release shall be governed by and construed in accordance with the laws of the Commonwealth of Pennsylvania. 

I understand and agree to this Agreement, have had the opportunity to review it with counsel, and have signed it freely and voluntarily.

  
 16 

					
	  
	 		 	  

		 		 	Date
			
	  
	 		 	  

	Witness (print name)	 		 	Witness (signature)

 Reviewed and agreed to on behalf of Globus Medical, Inc.: 

 

			
	By: 	 	

			
	Name:	 	  

			
	Title:	 	  

  
 17 

 EXHIBIT B 
 No Competition and Non-Disclosure Agreement 
  

					
	

	 	 GLOBUS MEDICAL, INC.

NO COMPETITION AND NON-DISCLOSURE AGREEMENT
	 	 Valley Forge Business Center
 2560 General Armistead Ave
 Audubon, PA 19403

Ph: (610) 930-1800

Fax: (610) 930-1697

http://www.globusmedical.com

 This No Competition and Non-Disclosure Agreement (“NCND Agreement”) is made and entered into
between Globus Medical, Inc., (the “Company”) and Richard Baron (“Employee”) effective January 3, 2012 (“Effective Date”). 

ACKNOWLEDGEMENTS & DEFINITIONS 
  

	A.	The Company is engaged in the design, development, production, distribution and sale of products and services related to the spine (“Products”).

  

	B.	Employee performs services for and on behalf of the Company, either as a direct employee or through an independent service contract, for which Company compensates
Employee. For purchases of this NCND Agreement the Employee’s performance of services and receipt of compensation from the Company will be defined as the Employment Agreement (the “Employment Agreement”) between the Employee of the
Company, whether or not a written employment agreement exists between the Employee and the Company governing said services and compensation. 

  

	C.	For purposes of this NCND Agreement, the No Competition Territory (“No Competition Territory”) shall be defined as the geographic area assigned to Employee
within the most recent 12 months of their employment. In the event that the Employee has been assigned certain accounts and not a geographic area, the No Competition Territory shall be defined as the geographic area within a 10-mile radius of each
assigned account. In the event the Employee has not been assigned specific accounts or a specific geographic region, the No Competition Territory shall be defined as the United States of America. 

 

	D.	Employee has received good and sufficient consideration from Company, including one or more of the following: an offer of employment; continued employment; salary;
health insurance benefits; bonuses; sales commissions; and stock options. 

  

	E.	For purposes of this NCND Agreement, Medical Personnel (“Medical Personnel”) shall be defined as orthopedic surgeons, neuro-surgeons, physicans, nurses and
other medical personnel involved in the implantation and other handling and usage of the Products. 

  

	F.	For purposes of this NCND Agreement, Hospitals (“Hospitals”) shall be defined as hospitals, surgery centers, medical centers and other health care facilities
that purchase Products and the location at which Medical Personnel perform services related to implantation and other handling and usage of the Products. 

  

	G.	 Employee will have access to confidential, proprietary and trade secret information

  
 18 

	 	
(“Confidential Information”) belonging to the Company, including Confidential Information developed by the Employee (see Section 2.2 below). Such Confidential Information
includes, but is not limited to: customer lists; product specifications and attributes; pricing information; technology development plans; forecasts; financial information; sales strategies and techniques; business records; models; prototypes;
schematics; manuals; handbooks; literature; vendors; business terms between Company and suppliers; business terms between Company and Hospitals; business terms between Company and distributors; business terms between Company and Medical Personnel.
Employee acknowledges that Company owns such Confidential Information and that Employee has no ownership interest in such Confidential Information. Furthermore, Employee acknowledges that the disclosure of such Confidential Information to
unauthorized third parties, including Competing Companies (as defined below) would cause great and irreparable harm to the Company. Furthermore, Employee acknowledges that Company has a legitimate business interest in the protection of the
Confidential Information. 

  

	H.	Employee will receive information and be trained in the highly technical, competitive and specialized business of spine surgery and spinal implants and instrumentation.

 NO COMPETITION & NO SOLICITATION COVENANT 

 

	1.1	Competitive Activity. For purposes of this NCND Agreement, Competitive Activity (“Competitive Activity”) shall be defined as participation in,
performance of services for, employment by, ownership of any interest in, or assistance, promotion or organization of, any person, partnership, corporation, firm, limited liability company, association or other business entity that manufactures,
sells, markets or distributed products or services used in spine surgery (“Competing Company”); providing that the purchase for investment of not more than five (5%) percent of the total capital stock of such Competing Company whose
stock is publicly traded shall not constitute a Competitive Activity. 

  

	1.2	No Competition Period. For purposes of this NCND Agreement, the No Competition Period (“No Competition Period”) shall be during the term of the
Employment Agreement Term and the 12-month period immediately following the termination of the Employment Agreement. 

  

	1.3	No Competition or Solicitation Covenant. Employee agrees not to engage in any Competitive Activity with any Competing Company during the No Competition Period in
the No Competition Territory. Furthermore, during the No Competition Period, Employee agrees not to, for the purchase of engaging in a Competitive Activity, directory or indirectly, either for the Employee’s benefit or the benefit of another
entity, solicit, call on, interfere with, or attempt to divert, entice away, sell to or market to any customer, Hospital or Medical Personnel in the No Competition Territory. 

 

	1.4	No Solicitation of Company’s Employees or Employees. During the No Competition Period, Employee agrees not to directly or indirectly, either for the
Employee’s benefit or the benefit of another entity, employ or offer to employ in any capacity, contact or recommend for employment with a Competing Company; contact or recommend for the purposes of entering into a contractual relationship with
a Competing Company; solicit, call on, interfere with, or attempt to divert, or entice away; any individuals who are or were employees, independent contractors, representatives or employees of the Company or of any of the Company’s distributors
on the date that the Employment Agreement was terminated or for the 12-month period immediately preceding the termination of the Employment Agreement. 

  
 19 

 NON-DISCLOSURE COVENANT 

 

	2.1	Use of Confidential Information. Both during the Employment Agreement Term and after the termination of the Employment Agreement, Employee agrees not to use any
Confidential Information except as required to perform its obligations as an Employee of the Company, or disclose to any individual, corporation, partnership or other entity any Confidential Information belonging to the Company, unless Employee is
required to make such disclosure pursuant to judicial process. Notwithstanding the foregoing, immediately upon receipt of subpoena or other judicial process requiring disclosure of Confidential Information belonging to Company, Employee shall
deliver written notice and a complete copy of such process to the Company and before responding to such process, allow the Company to take such action as they may deem appropriate under the circumstances to protect their interests in the
Confidential Information requested for disclosure. 

  

	2.2	Development of Intellectual Property. Employee may make, discover or develop inventions, ideas, trade secrets, financial materials, computer programs,
discoveries, developmental improvements, know-how, processes and devices related to or used in the conduct of Employee’s performance of services for and on behalf of the Company (“Developments”). The Employee agrees to disclose fully
and promptly to the Company any said Developments. Furthermore, Employee agrees that the Company is the sole and exclusive owner of said Developments; the Employee retains no ownership in said Developments; and said Developments become part of the
Company’s Confidential Information for purposes of this NCND Agreement. Company and Employee agree that if the Developments or any portion thereof are copyrightable, it shall be deemed “work for hire” as such term is defined in the
U.S. Copyright Act. The Employee shall execute and deliver to the Company any and all licenses, applications, assignments and other documents and take any and all actions that the Company may deem necessary or desirable to protect Company’s
ownership rights in said Developments. 

  

	2.3	Handling and Return of Confidential Information. Employee shall not physically or electronically remove or make copies of any Confidential Information owned by
the Company, except as required by the Employee to properly fulfill their responsibilities as an Employee of the Company. Upon the termination of the Employment Agreement, Employee shall immediately return to the Company any and all Confidential
Information in their possession, including any and all copies of said Confidential Information. 

  

	2.4	Fiduciary Duties. Employee agrees that Employee shall treat all Confidential Information entrusted to Employee by Company as a fiduciary, and Employee accepts
and undertakes all the obligations of a fiduciary, including good faith, trust, confidence and candor, to maintain, protect and develop Confidential Information for the benefit of Company. 

 

	2.5	Confidential Information of Others. Employee hereby represents and warrants to the Company that Employee is not bound by any agreement, understanding or
restriction, (including, but not limited to any covenant restricting competition or agreement related to the confidential and proprietary information and trade secrets of any third party), that is inconsistent with or prevents or limits the
Employee’s ability to fulfill their obligations under the Employment Agreement. Furthermore, Employee hereby represents and warrants to the Company that the execution and performance of the Employment Agreement will not result in or constitute
a breach of any term or condition of any other agreement the Employee is bound by. In performance of his duties and obligations under the Employment Agreement, Employee agrees not to disclose the confidential and proprietary information or trade
secrets of any third party to the Company. 

 REMEDIES 

 

	3.1	 Right to Specific Relief. Company and Employee recognize and acknowledge that the limitations set forth in this NCND Agreement are properly
required for the adequate protection of the business of the Company, 

  
 20 

	 	
and that violation of any of the provisions of this NCND Agreement will cause irreparable injury for which money damages are neither adequate nor ascertainable. Accordingly, Company shall have
the right to have the provisions of this NCND Agreement specifically enforced by a court of competent jurisdiction, in addition to any other remedies which Company may have, and Employee hereby consents to the entry of an injunction or other similar
relief without the necessity of posting a bond or other financial insurance. Furthermore, Company shall be entitled to recover its costs and expenses (including reasonable attorneys’ fees) incurred in enforcing its rights under this NCND
Agreement. 

 OTHER MATTERS 

 

	4.1	Entire Agreement. This NCND Agreement constitutes the entire agreement between the parties relating to the specific matters covered by this NCND Agreement and
supersedes all prior agreements, whether written or oral. No modifications or waiver of any part of this NCND Agreement shall be binding upon either party unless in writing. 

 

	4.2	Waiver. The waiver of a breach of any provision of this NCND Agreement by any party shall not operate or be construed as a waiver of any provision of this NCND
Agreement or consent of any subsequent breach. 

  

	4.4	Severability. If any term or provision of this NCND Agreement shall be determined invalid or unenforceable to any extent or in any application, then the
remainder of this NCND Agreement shall not be affected thereby, and such term or provision shall be deemed modified to the minimum extent necessary to make it consistent with applicable law, except to such extent or in such application, shall not be
affected thereby, every term and provision of this NCND Agreement as so modified if necessary, shall be enforced to the fullest extent and in the broadest application permitted by law . 

 

	4.5	Governing Law. In order to maintain uniformity in the interpretation of this NCND Agreement the parties have expressly agreed that this NCND Agreement, the
parties’ performance hereunder and the relationship between them shall be governed by, construed and enforced in accordance with the laws of the Commonwealth of Pennsylvania, without regard to the principles thereof regarding conflicts of laws.

  

	4.6	Binding Nature. This Agreement shall be binding upon and inure to the benefit of the parties hereto and to the Company’s successors, representatives and
permitted assigns. 

 IN WITNESS WHEREOF, the undersigned have executed this NCND AGREEMENT, intending to be bound
under their seals, effective as of the day and year set forth above. 
  

									
	COMPANY:        Globus Medical, Inc.	 		 	EMPLOYEE:
					
	By:	 	  
	 		 	By:	 	 /s/ Richard Baron

 

							
	DATE:	 		 	DATE:	 	
				
	  
	 		 	January 2, 2012	 	

  
 21

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00203-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00203-of-00352.parquet"}]]